(Q46009385)

English

Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression.

scientific article published on 14 May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

immunosuppression

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Julia Yuen-Shan Tsang

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Shuiping Jiang

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Eva Leung

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kulachelvy Ratnasothy

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Giovanna Lombardi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Robert Lechler

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

14 May 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Transplant Immunology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

203-209

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Low circulating regulatory T-cell levels after acute rejection in liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Regulatory CD25+ T cells in human kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

CD4+ regulatory cells as a potential immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Regulatory T-cell physiology and application to treat autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Influence of direct and indirect allorecognition pathways on CD4+CD25+ regulatory T-cell function in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Inhibition of human CD4(+)CD25(+high) regulatory T cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

The role of peripheral T-cell deletion in transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2009.05.003

7 January 2021

Identifiers

10.1016/J.TRIM.2009.05.003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19446634%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46009385&oldid=1367438396"